Log in to save to my catalogue

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e612d970f93d4e71a7d4a7c0041cc2a2

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

About this item

Full title

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

Publisher

Switzerland: MDPI AG

Journal title

Cells (Basel, Switzerland), 2020-01, Vol.9 (1), p.198

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The RAS/RAF/MEK/ERK (MAPK) signaling cascade is essential for cell inter- and intra-cellular communication, which regulates fundamental cell functions such as growth, survival, and differentiation. The MAPK pathway also integrates signals from complex intracellular networks in performing cellular functions. Despite the initial discovery of the core...

Alternative Titles

Full title

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e612d970f93d4e71a7d4a7c0041cc2a2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e612d970f93d4e71a7d4a7c0041cc2a2

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells9010198

How to access this item